Translator Disclaimer
6 July 2018 Towards clinic-friendly solutions for patient trials in breast cancer phase contrast imaging
Author Affiliations +
Proceedings Volume 10718, 14th International Workshop on Breast Imaging (IWBI 2018); 107181P (2018) https://doi.org/10.1117/12.2316498
Event: The Fourteenth International Workshop on Breast Imaging, 2018, Atlanta, Georgia, United States
Abstract
Phase-contrast imaging of the breast is expected to deliver significantly improved image quality and diagnostic value at a reduced radiation dose compared to present-day 2D X-ray mammography, digital breast tomosynthesis (DBT) and computed tomography (CT) and become a viable method for early diagnosis of breast cancer in women. This paper builds upon the evaluation of a novel protocol to evaluate 3D mammographic phase contrast imaging for the detection of breast cancer undertaken with a purpose designed phantom and selected breast cancer specimens. Following evaluation, propagation-based phase contrast imaging was demonstrated to have high contrast to noise ratio alongside an important reduction in radiation dose. The challenge now is to shift the focus of research to real clinic solutions, with the worldfirst demonstration of X-ray in-line full field phase-contrast mammographic tomography (PCT) with cancer patients through an international collaboration of a multi-disciplinary team.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Sarah J. Lewis, Timur E. Gureyev, Patrycja Baran, Seyedamir Tavakoli Taba, Serena Pacile, Christian Dullin, Giuliana Tromba, Daniel Hausermann, Andrew Peele, Darren Lockie, and Patrick C. Brennan "Towards clinic-friendly solutions for patient trials in breast cancer phase contrast imaging", Proc. SPIE 10718, 14th International Workshop on Breast Imaging (IWBI 2018), 107181P (6 July 2018); https://doi.org/10.1117/12.2316498
PROCEEDINGS
6 PAGES


SHARE
Advertisement
Advertisement
Back to Top